Back To: Home

CLICK HERE FOR WHAT'S NEW IN:
 




 

Collaborating for MDx kits
October 2016
SHARING OPTIONS:

CARLSBAD, Calif. & NINGBO, China—A new collaboration was announced recently between Thermo Fisher Scientific and HEALTH BioMed (HBM) to support the latter's development of molecular diagnostic kits for infectious disease and pharmacogenomics screening for the China market. Per the companies' strategic agreement, HBM will submit all kits developed on the Applied Biosystems 3500Dx Capillary Electrophoresis platform through the regulatory process with the China Food and Drug Administration once successfully validated. No financial terms were disclosed.
 
“Our collaboration with Thermo Fisher Scientific will enable HBM to meet a critical need in the China market for a series of high-accuracy kits designed to run on a single CE platform to improve human health outcomes,” said Jianwei Yu, chairman and CEO of HEALTH BioMed. “Molecular diagnostics such as these can improve diagnosis and treatment strategies in hospital settings while also helping to decrease antibiotic abuse.”

Back



PAGE UTILITIES


CONTACT US
DDNEWS
Published by Old River Publications LLC
19035 Old Detroit Road
Rocky River, OH USA 44116
Ph: 440-331-6600  |  Fax: 440-331-7563
 
© Copyright 2017 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.